SEC 13F Intelligence

Rapt Therapeutics, Inc.

CUSIP 75382E909

Rapt Therapeutics, Inc. has 1 institutional holders in Filings Flow’s 13F database, together reporting 12.4K shares worth $244,000 as of Q4 2020. The largest reported holders are Group One Trading LLC, Simplex Trading, LLC, and Concourse Financial Group Securities, Inc..

Institutional Holders
1
Q4 2020
Reported Value
$244,000
Ticker
unmapped
private placement or foreign
Quarters Tracked
1

Ownership Trend

Institutional holders
Q4 ’20: 1Q4 ’20filingsflow.com
Total reported value
Q4 ’20: $244,000Q4 ’20filingsflow.com

Holders

Manager% of PortfolioValueSharesQuarter
GROUP ONE TRADING LLC$52.2B AUM0.00%$95,59060.5KQ1 2025
SIMPLEX TRADING, LLC$149.1B AUM0.00%$1,0001.0KQ1 2025

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.